..

2015

77 160/90,
(LDL = 150 mg%
120 mg%, TG = 160 mg%, HDL = 40
mg%)

1.
2.
3.
4.

77
160/90,
:LDL = 150 mg% %
TG=160mg, HDL = 40 mg%)
120mg%

1.1.
1. 200
mg/dl
,
.


.

2. 126 mg/dl
8 .

3.
2 75 g 200 mg/dl.

 1.2.

1. : 126 mg/dl
/ 2 OGTT 200 mg/dl
2. (IFG):
100-125 mg/dl

2 OGTT < 140 mg/dl

OGTT*
3. (IGT):
< 126
2 OGTT 140 <200 mg/dl
* OGTT
IFG IGT.

30 min / ,
5 /
(5-10% )

(>25 /) & (2
/)
&
, :
- < 35% . .
- < 7% . .
- Trans < 1% . .
- < 300 mg
< 5 gr
(<10-20 / , <20-30 / )

& ,

ESC/EAS Guidelines on Dylslipidemias, European Heart Journal 2011;32 (14):1769-1818, Atherosclerosis 2011 Jul;217(1):3-46

77

IGF

RESULTS (RECOMMENDATIONS)

ABSTRACT|THE PROCESS|QUESTIONS GUIDING THE EVIDENCE REVIEW|THE EVIDENCE REVIEW|RESULTS

(RECOMMENDATIONS)|LIMITATIONS|DISCUSSION|CONCLUSIONS|ARTICLE INFORMATION|REFERENCES
The following recommendations are based on the systematic evidence review described above (Box).
Recommendations 1 through 5 address questions 1 and 2 concerning thresholds and goals for BP treatment.
Recommendations 6, 7, and 8 address question 3 concerning selection of antihypertensive drugs.
Recommendation 9 is a summary of strategies based on expert opinion for starting and adding
antihypertensive drugs. The evidence statements supporting the recommendations are in the
onlineSupplement.
Box.
Recommendations for Management of Hypertension
Recommendation 1
In the general population aged 60 years, initiate pharmacologic treatment to lower blood pressure (BP) at
systolic blood pressure (SBP) 150 mm Hg or diastolic blood pressure (DBP) 90 mm Hg and treat to a goal
SBP <150 mm Hg and goal DBP <90 mm Hg. (Strong Recommendation Grade A)
Corollary Recommendation
In the general population aged 60 years, if pharmacologic treatment for high BP results in lower achieved
SBP (eg, <140 mm Hg) and treatment is well tolerated and without adverse effects on health or quality of
life, treatment does not need to be adjusted. (Expert Opinion Grade E)
Recommendation 2
In the general population <60 years, initiate pharmacologic treatment to lower BP at DBP 90 mm Hg and
treat to a goal DBP <90 mm Hg. (For ages 30-59 years, Strong Recommendation Grade A; For ages 18-29
years, Expert Opinion Grade E)
Recommendation 3
In the general population <60 years, initiate pharmacologic treatment to lower BP at SBP 140 mm Hg and
treat to a goal SBP <140 mm Hg. (Expert Opinion Grade E)
Recommendation 4
In the population aged 18 years with chronic

From: 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the
Panel Members Appointed to the Eighth Joint National Committee (JNC 8)
JAMA. 2014;311(5):507-520. doi:10.1001/jama.2013.284427

Figure Legend:
2014 Hypertension Guideline Management AlgorithmSBP indicates systolic blood pressure; DBP, diastolic blood pressure; ACEI,
angiotensin-converting enzyme; ARB, angiotensin receptor blocker; and CCB, calcium channel blocker. aACEIs and ARBs should
not be used in combination.bIf blood pressure fails to be maintained at goal, reenter the algorithm where appropriate based on the
current individual therapeutic plan.
Copyright 2015 American Medical
Date of download: 2/14/2015

Association. All rights reserved.

77

IGF/IGT

 LDL-C 70-189mg/dl
( )

10
ASCVD score Pool Cohort Risk Assesment
Equations.

1)

10 7,5% :

2)

().

10 < 7,5% :

(C).
Y , .,

().
Stone NJ, et al.
2013 ACC/AHA Blood Cholesterol Guidelines


1.

: M LDL-C > 50%

(.. 40-80mg,
20-40mg).

2.

: M LDL-C 30%
<50%
(.. 10-20mg,
5-10mg, 20-40mg).

3.

: M LDL-C < 30%

(.. 10mg, 10-20mg).

:
Valsartan160mg
pitavastatin2mg

A (mmHg)

160 /80

140/80

LDL-C (mg/dL)

150

98

HDL-C (mg/dL)

40

44

TG (mg/dL)

160

140

Fast.Gluc (mg/dL)

120

115

START LOW, GO SLOW